Data

Prescriptive Data and Jamestown Partner to Provide Carbon Cutting Smart Building Solutions at Waterfront Plaza

Retrieved on: 
Wednesday, February 9, 2022
Environment, Commercial Building & Real Estate, Technology, Construction & Property, Other Energy, Other Technology, Software, Building Systems, Energy, Other Construction & Property, Giant, Maintenance, Bay Wheels, Tenant, Artificial intelligence, Machine learning, Ghirardelli Square, Gold, Egunyu Janepher Nantume, Waterfront, BART, Transport, Automation, Times Square, United Nations Sustainable Development Group, HVAC, Innovation, Bay Area Rapid Transit, Chelsea Market, Data, Efficiency, The RealReal, Technology, Â, ML, Safety, Compliance, Building, Learning, CEO, Flood, Health, WeWork, Goal, LEED, Leadership in Energy and Environmental Design, Intelligence, COO, Carbon, Social, Partnership, Mobile phone, Renewable energy, Industrial Internet Consortium

The technology company will implement its market-leading Nantum OS smart building operating system at Jamestowns Waterfront Plaza, a 437,800-square-foot office campus in San Francisco.

Key Points: 
  • The technology company will implement its market-leading Nantum OS smart building operating system at Jamestowns Waterfront Plaza, a 437,800-square-foot office campus in San Francisco.
  • The Nantum OS pilot at Waterfront Plaza will inform our strategy to reach net zero carbon emissions portfolio-wide by 2050.
  • Located along San Franciscos renowned Northern Waterfront, Waterfront Plaza offers large, efficient floor plans and features floor-to-ceiling windows providing an abundance of natural light.
  • Were thrilled that theyve selected Prescriptive Data to be their platform of choice at Waterfront Plaza.

Omega Venture Partners Closes $115+ Million VC Fund to Invest in Fast Growing AI-Enabled Companies that Solve High-Value Business Problems

Retrieved on: 
Wednesday, February 9, 2022
PALO, Artificial intelligence, AI, Digitization, Elemental Machines, Omega, Fortune 500, Solution, Investment, Technology, ML, CEO, Data, MIT, Silicon, ROI, Machine learning, Partner, Partnership, Mervin F. Verbit, Cryptocurrency, Dietary supplement, Medical device, Automation, Superside (company)

In 2021 Omega Venture Partners completed twelve investments ten into new portfolio companies as well as participating in the follow-on financings of two existing companies.

Key Points: 
  • In 2021 Omega Venture Partners completed twelve investments ten into new portfolio companies as well as participating in the follow-on financings of two existing companies.
  • "Omega Venture Partners is an excellent partner for our company," said Ross Buhrdorf, CEO of ZenBusiness, Inc. "The resources, contacts, and exceptional knowledge that Omega brings to the table is truly outstanding.
  • Omega also partners with preeminent authorities from MIT , combining deep domain expertise with a successful track record in technology investing.
  • The firm employs a thematic investment strategy to identify large market opportunities and invest in the next generation of category-defining companies.Visit: https://www.omegavp.com/

Ankura Adds Transformative Data and Technology Capability with Acquisition of Noragh Analytics

Retrieved on: 
Wednesday, February 9, 2022
Industry, Fraud, Senior, Government, Artificial intelligence, Company, Growth, Atlantic Fleet, Multimedia, IP, Wardwell, Technology, Create, Acquisition, Solution, Terror, Data management, Risk, Data Intercept Technology Unit, Collection, Atlantic Fleet (United Kingdom), Method, Sidley Austin, Data, Intelligence, Database, Insurance, United States Navy, Behavior, Machine learning, LLC, Online shopping, Sales

The Noragh proprietary platforms gather both structured and unstructured data from internal and external data sources into comprehensive database networks.

Key Points: 
  • The Noragh proprietary platforms gather both structured and unstructured data from internal and external data sources into comprehensive database networks.
  • The acquisition complements and expands Ankura's market-leading Data and Technology offerings and places the Firm squarely at the forefront of the application of transformative artificial intelligence and machine learning solutions for business and commercial application.
  • The platforms' methods of applying data solutions enables artificial intelligence technology and expands Ankura's ability to generate key insights from big data to deliver solutions for clients facing complex, cross-disciplinary issues.
  • "Acquiring Noragh Analytics marks an exciting milestone in the continued growth of Ankura's advanced data analytics and technology enabled consulting capabilities worldwide.

New Data Certifications Extend CompTIA Product Roadmap

Retrieved on: 
Wednesday, February 9, 2022
Data visualization, Industry, Human, Organization, CompTIA, Data analysis, Data, Thibodeaux, Data science, Technology, Data management, Learning, CEO, Workforce, Association, Occupation, Data mining, Information technology, Education, Certification, Medicine

CompTIA Data+ is an early-career data analytics certification for professionals tasked with developing and promoting data-driven business decision-making.

Key Points: 
  • CompTIA Data+ is an early-career data analytics certification for professionals tasked with developing and promoting data-driven business decision-making.
  • Additional new certifications and learning materials centered on data knowledge and skills will be introduced beginning in 2023, with resources available for all career levels early (CompTIA Data Foundations), intermediate for data analytics (CompTIA Data+) and data systems (CompTIA DataSys+) and advanced data science (CompTIA DataSci+).
  • During the past 12 months, there were over 193,000 job postings by U.S. employers for data analysts, data mining specialists, data engineers and data scientists.
  • Employers listed over one million job postings over the past 12 months seeking candidates with skills in data analysis, data mining or data visualization.

Starburst Raises $250 Million to Lead the Market Shift to Faster Analytics on Decentralized Data

Retrieved on: 
Wednesday, February 9, 2022
Cloud, People, Starburst galaxy, Alibaba Cloud, Fraud, Partner, Artificial intelligence, Growth, Red, Azure, Technology, Zillow, FINRA, Solution, Innovation, Investment, AWS, Facebook, Standard Chartered, SQL, Software as a service, Red Hat, Data management, Architecture, Business operations, Ali Baba, Salesforce, CEO, Index Ventures, HPE, Organization, Capital Group Companies, GCP, Comcast, Database, Altimeter, Coatue Management, Partnership, ARR, Shell, VP, Slalom, Computer data storage, Electronic component, Priceline, Starburst, Data

BOSTON, Feb. 9, 2022 /PRNewswire/ -- Starburst, the analytics anywhere company, today announced it has secured a $250 million Series D funding round at a $3.35 billion valuation. The financing round was led by Alkeon Capital, with participation from Altimeter and B Capital Group, as well as existing investors Andreessen Horowitz, Coatue Management, Index Ventures and Salesforce Ventures. The round brings Starburst's total financing to date to $414 million, as the company ramps up operations to meet the industry's growing demand for faster analytics on decentralized data.

Key Points: 
  • The round brings Starburst's total financing to date to $414 million, as the company ramps up operations to meet the industry's growing demand for faster analytics on decentralized data.
  • "Starburst streamlines data access and analytics across silos, clouds and business lines, enabling organizations to become truly data driven.
  • This data centralization approach, commonly associated with data warehousing, requires data to move and be prepared prior to analyzing it.
  • Starburst is foundational to Data Mesh , a new approach to data management based on distributed data and treating data as a product.

Starburst Unveils New Data Product Functionality to Accelerate Data Mesh Journey

Retrieved on: 
Wednesday, February 9, 2022
Cloud, Gartner, Computer science, History of the University of Maryland, College Park, Engineering, Conference, FINRA, Dataproducts, Investment, Data management, Scale, Metadata, Ownership, University, CEO, Starburst, Data fabrication, Comcast, Accenture, Database, Master Class, Cryptocurrency, Apple, Data

BOSTON, Feb. 9, 2022 /PRNewswire/ -- To kick off its annual Datanova conference, Starburst, the analytics anywhere company, today announced a suite of new capabilities for its marquee product, Starburst Enterprise. Starburst Enterprise now includes features that allow companies to build & share data products, and the necessary native access controls that form the foundation of a Data Mesh implementation. The new capabilities will be showcased at Datanova, the two-day virtual event that is focused around Data Mesh, a new distributed architectural approach to data management.

Key Points: 
  • Data Mesh aims to prescribe that the ownership of data products should live in business domains, ensuring that data is treated as a first-class product across the organization.
  • By delivering data as a product, companies can empower business domains to become truly data-driven while freeing data teams from costly, time-intensive data management tasks.
  • Starburst and Starburst Enterprise provide the data access and analytics engine to accelerate and simplify an organization's Data Mesh journey.
  • We provide the fastest, most efficient analytics engine for your data warehouse, data lake, or data mesh.

X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

Retrieved on: 
Wednesday, February 9, 2022
Artificial intelligence, AI, ADME, Solution, API, Machine learning, Data science, Technology, Chem, DEL, Data, Partnership, Tox, Drug discovery, Pharmaceutical industry, Medical device, Fine chemical

Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates.

Key Points: 
  • Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates.
  • "This is a perfect match between two of the best solutions for some hard challenges in drug discovery," saidNorman Azoulay, Director, Scientific Products.
  • GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study .
  • For more information about GOSTAR, visit https://www.gostardb.com/
    X-Chem is a leader in small molecule drug discovery services for pharmaceutical and biotech companies.

TDS and UScellular to release fourth quarter operating results and host conference call on Feb. 18, 2022

Retrieved on: 
Wednesday, February 9, 2022
TDS, Human, Solution, Fortune 1000, Telephone and Data Systems, Telephone, Data, U.S. Cellular, NYSE, TDS Telecom, USM, Webcast, Mobile phone

CHICAGO, Feb. 9, 2022 /PRNewswire/ -- Telephone and Data Systems (NYSE: TDS) andUnited States Cellular Corporation(NYSE:USM) will be webcasting their fourth quarter operating results conference call onFeb 18, 2022, at9:00 a.m. central time.

Key Points: 
  • CHICAGO, Feb. 9, 2022 /PRNewswire/ -- Telephone and Data Systems (NYSE: TDS) andUnited States Cellular Corporation(NYSE:USM) will be webcasting their fourth quarter operating results conference call onFeb 18, 2022, at9:00 a.m. central time.
  • The companies will release their financial results onFebruary 17, 2022after market close.
  • To listen to the webcast, please visit the events & presentations pages of investors.tdsinc.com or investors.uscellular.com .
  • Founded in 1969 and headquartered in Chicago, TDS employed approximately 8,900 associates as of September 30, 2021.

Pavilion HyperParallel Data Platform Named "Top 5 Storage For Life Sciences Solution" By DCIG

Retrieved on: 
Wednesday, February 9, 2022
Acceleration, Industry, List of life sciences, IO, Radiology, Time, Research, GPU, Storage, Data, NVME, HPC, Organization, Failure, Cryogenic electron microscopy, Pavilion, LinkedIn, Genomics, SAN, Computer data storage, Pharmaceutical industry

SAN JOSE, Calif., Feb. 9, 2022 /PRNewswire/ -- Pavilion Data Systems , the leader in advanced data storage solutions, announced that its HyperParallel Data Platform has been named a 2022-23 "Top 5 Storage for Life Sciences Solution" by the Data Center Intelligence Group (DCIG) , an IT industry analyst firm.

Key Points: 
  • SAN JOSE, Calif., Feb. 9, 2022 /PRNewswire/ -- Pavilion Data Systems , the leader in advanced data storage solutions, announced that its HyperParallel Data Platform has been named a 2022-23 "Top 5 Storage for Life Sciences Solution" by the Data Center Intelligence Group (DCIG) , an IT industry analyst firm.
  • DCIG's 2022-23 "Top 5 Storage for Life Sciences Solutions" report underscored the need for high performance storage in life sciences analysis.
  • "We are pleased to accept the DCIG data storage Top 5 Award for Life Sciences," said Shridar Subramanian, Chief Marketing/Product Officer, Pavilion Data Systems.
  • To learn more about the DCIG "Top 5 Storage for Life Sciences Solutions" report, along with a profile of the Pavilion HyperParallel Data Platform, download the industry brief here .

X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

Retrieved on: 
Wednesday, February 9, 2022
Artificial intelligence, AI, ADME, Solution, API, Machine learning, Data science, Technology, Chem, DEL, Data, Partnership, Tox, Drug discovery, Pharmaceutical industry, Medical device, Fine chemical

Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates.

Key Points: 
  • Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates.
  • "This is a perfect match between two of the best solutions for some hard challenges in drug discovery," saidNorman Azoulay, Director, Scientific Products.
  • GOSTAR's proprietary data set underwent rigorous analysis and large-scale ML model building to predict drug solubility in a recent joint study .
  • For more information about GOSTAR, visit https://www.gostardb.com/
    X-Chem is a leader in small molecule drug discovery services for pharmaceutical and biotech companies.